NFKB1 and malignant colon neoplasm: Rakitina and co-authors reported that HSP90 inhibitors were effective in enhancing oxaliplatin-dependent caspase activation and cytotoxicity by down-regulating anti-apoptotic signaling and activating NF-κB in colon cancer cells [23].